Linde Gas Therapeutics Benelux B.V. Sustainability Profile
Linde Gas Therapeutics Benelux B.V., a prominent player in the medical gas industry, is headquartered in the Netherlands and operates extensively across the Benelux region. Founded in the early 2000s, the company has established itself as a leader in providing innovative gas solutions for healthcare applications, including anaesthesia, respiratory care, and critical care. Linde Gas Therapeutics is renowned for its high-quality medical gases and advanced delivery systems, which are designed to enhance patient safety and treatment efficacy. The company’s commitment to research and development has led to significant advancements in gas therapy, positioning it as a trusted partner for healthcare providers. With a strong market presence and a focus on sustainability, Linde Gas Therapeutics continues to set benchmarks in the industry, ensuring optimal patient outcomes and operational excellence.
DitchCarbon Score
How does Linde Gas Therapeutics Benelux B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Linde Gas Therapeutics Benelux B.V.'s score of 48 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Linde Gas Therapeutics Benelux B.V., headquartered in the Netherlands (NL), currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Linde plc, which cascades its climate commitments and performance metrics down to its subsidiaries. While Linde Gas Therapeutics Benelux B.V. has not set specific reduction targets or initiatives at this level, it aligns with the broader sustainability goals of Linde plc. The parent company has established science-based targets (SBTi) and participates in various climate initiatives, including the Carbon Disclosure Project (CDP). These commitments reflect a strong corporate responsibility towards reducing carbon emissions and addressing climate change. As a subsidiary, Linde Gas Therapeutics Benelux B.V. is expected to adhere to the sustainability practices and targets set by Linde plc, contributing to the overall reduction of greenhouse gas emissions within the corporate family. However, specific details regarding their individual climate strategies or performance metrics remain unspecified at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 16,872,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
| Scope 2 | 23,518,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
| Scope 3 | 14,849,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Linde Gas Therapeutics Benelux B.V.'s Industry?
How Carbon Intensive is Linde Gas Therapeutics Benelux B.V.'s Location?
Linde Gas Therapeutics Benelux B.V.'s Scope 3 Categories Breakdown
Linde Gas Therapeutics Benelux B.V.'s Scope 3 emissions, which decreased by 35% last year and increased by approximately 8% since 2018, demonstrating supply chain emissions tracking. A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 30% of total emissions under the GHG Protocol, with "Fuel and Energy Related Activities" being the largest emissions source at 35% of Scope 3 emissions.
Top Scope 3 Categories
Linde Gas Therapeutics Benelux B.V.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Linde Gas Therapeutics Benelux B.V. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.